mutagenesis was performed using a modified QuikChange TM mutagenesis protocol. The PCR products were gel purified, digested with DpnI, repaired using
Gibson Mix TM , and directed transformed into E. coli strain BL21(DE3).
Determination of P450 concentration. Concentration of P450/P411 enzymes was determined from ferrous carbon monoxide binding difference spectra using previously reported extinction coefficients for cysteine-ligated ( = 91,000 M -1 cm -1 ) and serine-ligated enzymes ( = 103,000 M -1 cm -1 ).
Protein expression and purification. Enzymes used in purified protein experiments were expressed in BL21(DE3) E. coli cultures transformed with plasmid encoding P450 or P411 variants. Expression and purification was performed as described except that the shake rate was lowered to 130 RPM during expression. 2 Following expression, cells were pelleted and frozen at -20 °C. For purification, frozen cells were resuspended in buffer A (20 mM tris, 20 mM imidazole, 100 mM NaCl, pH 7.5, 4 mL/g of cell wet weight) and disrupted by sonication (2 x 1 min, output control 5, 50% duty cycle; Sonicator 3000, Misonix, Inc.). To pellet insoluble material, lysates were centrifuged at 24,000 x g for 0.5 h at 4 °C. Proteins were expressed in a construct containing a 6x-His tag and were consequently purified using a nickel NTA column (5 mL HisTrap HP, GE Healthcare, Piscataway, NJ) using an AKTAxpress purifier FPLC system (GE healthcare). P450 or P411 enzymes were then eluted on a linear gradient from 100% buffer A 0% buffer B (20 mM tris, 300 mM imidazole, 100 mM NaCl, pH 7.5) to 100 % buffer B over 10 column volumes (P450/P411 enzymes elute at
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around 80 mM imidazole). Fractions containing P450 or P411 enzymes were pooled, concentrated, and subjected to three exchanges of phosphate buffer (0.1 M KPi pH 8.0) to remove excess salt and imidazole. Concentrated proteins were aliquoted, flash-frozen on powdered dry ice, and stored at -20 °C until later use.
Reaction screening in 96-well plate format. Site-saturation libraries were generated by employing the "22c-trick" method. anaerobic chamber. The pellets were resuspended in 300 μL argon sparged reaction buffer (4:1 M9-N/glucose (250 mM)). GOX solution (10x, 40 μL/well) was added to each well followed by azide 1 (100 mM, 10 μL/well). The plate was sealed with aluminum sealing tape, removed from the anaerobic chamber, and shaken at 40 rpm. After 12 hours, the seal was removed and 500 μL of acetonitrile and 10 μL of standard (10 mM) were added to each well. The plate was vortexed and centrifuged (4000g, 30 minutes) and 500 μL aliquots were transferred to a shallow-well plate for analysis by HPLC.
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Typical procedure for small-scale amination bioconversions under anaerobic conditions using whole cells. E. coli BL21(DE3) cells containing P450 or P411 enzymes were expressed and resuspended to an OD 600 =30 in M9-N), and then degassed by sparging with argon in a sealed 6 mL crimp vial for at least 30 mintues. Separately, glucose (250 mM dissolved in 1X M9-N, 40 μL, or multiples thereof) was degassed by sparging with argon for at least five minutes.
The oxygen quenching mixture (40 μL) was added to a 2 mL crimp vial containing stir bars. All solutions were uncapped and transferred into an anaerobic chamber. Resuspended cells (300 μL) were added to the vial containing the oxygen quenching mixture, followed by glucose (50 μL), and substrate (100 mM arylsulfonyl azide, 10 μL in DMSO). The vial was sealed, removed from the anaerobic chamber and stirred at room temperature for 8h. Synchrotron Radiation Laboratory Beamline 12-2. Data were processed using XDS in the spacegroup P4 2 2 1 2 to 2.66 Å resolution. 4 The structure of P411BM3-CIS-T438S-I263F was solved by molecular replacement using the Phaser program, 5 as implemented in CCP4,
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P411BM3-CIS structure [PDB ID: 4H23] as the search model. Model building was performed in
Coot and restrained refinement in Refmac5. 7 Model quality was assessed with the MolProbity online server. 8 TLS operators were included in the last round of refinement. 9 Crystallographic and model statistics are described in Table S1 . -CIS T438S  P411 BM3 -CIS-T438S-I263F  P411 BM3 -CIS T438S, I263F  P411 BM3 -CIS-T438S-I263F-A268T P411 BM3 -CIS T438S, I263F, A268T  P450 BM3 -CIS-T438S-I263F  P450 BM3 -CIS T438S, I263F  P411 BM3 -MAN1-T268A  V78A, F81L, A82T, F87A, P142S, T175I, A184V,  F205C, S226R, H236Q, E252G, R255S, A290V,  L353V, C400S  P411 BM3 -MAN1-T268A-M263I  V78L, F87A, P142S, T175I, A184T, F205C,  S226R, H236Q, E252G, R255S, A290V, G315S,  A330V, L353V, T268A, C400S  P411 BM3 -T268A-F87A  C400S-T268A-F87A  P411 BM3 -T268A-F87V  C400S-T268A-F87V  P411 BM3 -CIS-T438S-I263F-F87A  P411 BM3 -CIS T438S, I263F S11 Conditions for whole-cell catalysis -Cells resuspended to OD 600 = 30 in M9-N (300 μL), GOX mixture (10x 14,000U catalase/1,000U glucose oxidase per mL) (40 μL), 250 mM Glucose (50 uL), 100 mM azide 1 (10 μL). 
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